Skip to main content
Professional Technical IVT

pubertal suppression therapy

Medical treatment using GnRH agonists to temporarily halt pubertal development in adolescents. Often discussed in contexts of gender dysphoria or precocious puberty management.

Full Definition

Pubertal suppression therapy involves the administration of gonadotropin-releasing hormone (GnRH) agonists to temporarily pause pubertal development in adolescents. This reversible treatment is primarily used for gender dysphoria management, allowing time for psychological exploration, or for treating central precocious puberty. The therapy suppresses the hypothalamic-pituitary-gonadal axis, effectively halting the progression of secondary sexual characteristics. Medical editors must distinguish this from pubertal blocking, which is often used synonymously but may have subtle clinical distinctions in different contexts.

Usage

Usage note: Use specific terminology rather than colloquial terms like 'puberty blockers' in formal medical documentation.

In Context

  • "The multidisciplinary team recommended pubertal suppression therapy after extensive psychological evaluation." — Clinical case report
  • "Informed consent for pubertal suppression therapy requires discussion of reversibility and long-term bone health implications." — Medical ethics documentation

Also known as

pubertal pause puberty suppression

Contrasted with

pubertal induction

Don't confuse with

pubertal blocking hormone replacement therapy pubertal delay

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON